Contents
The human papillomavirus (HPV) vaccine can reduce the incidence of cervical cancer by up to 90 percent. The latest research has been published in the Lancet. They included adolescents under the UK immunization program. – This is a historic moment – specialists emphasize.
- Cervical cancer causes five deaths a day in Poland. It kills 300 in the world. women every year
- 99 percent cases are caused by the human papillomavirus (HPV). There are over 100 of them
- Subsequent studies show that a massive HPV vaccination program reduces the risk of cervical cancer by nearly 90 percent.
- There is still no vaccination program for teenagers in Poland
- More information can be found on the TvoiLokony home page
The HPV vaccine is 90 percent effective.
The human papillomavirus (HPV) vaccine reduces the incidence of cervical cancer by nearly 90 percent. – show the latest data from Great Britain. The results of the research were published in the medical journal Lancet.
Experts looked at data from the human papillomavirus (HPV) vaccination program using the Cervarix vaccine, which was given to girls from 2008 to September 2012 in the UK.
The effects are amazing. Cervical cancer cases fell by 87%. compared to the unvaccinated population. I am talking about a group of girls who received the vaccine at the age of 12-13. In the 14-16 age group, this decrease was 62%, and in older teenagers (16-18 years old) – 34%.
The study also showed 97 percent. decrease in precancerous conditions (cervical dysplasia) in vaccinated girls aged 12 to 13, 75% in girls who were vaccinated between 14 and 16 years of age and 39 percent. in the group of 16-18 years.
The rest of the article under the video.
Estimates say the HPV vaccination program prevented around 450 cancers and over 17 deaths. precancerous conditions. The researchers say the cervical cancer cases in the study group dropped from around 50 per year to just five.
“Following the introduction of the HPV vaccination program in England, we have seen a significant reduction in the incidence of cervical cancer and CIN3 cervical dysplasia, especially among those offered the vaccine aged 12–13 years. The HPV vaccination program has almost completely eliminated cervical cancer in women born after September 1, 1995.»- we read on the website« The Lancet ».
Another vaccine, Gardasil, is currently used in the program. It is offered to girls aged 11 to 13. From 2019, the vaccine is also offered to boys.
- HPV – an oncogenic virus causes cervical cancer
The HPV vaccine has a short history. It was developed in 2006. It is still unclear how long protection lasts and whether a booster dose in middle age will be needed.
Cervical cancer – a historic moment
Cancer Research UK, a British charity dedicated to supporting cancer research, said the results have turned out better than expected and that cervical cancer could become a rare disease thanks to vaccines combined with screening.
– These results show the power of science. This is a historic moment to see the first study showing that the HPV vaccine protects and will protect thousands of women from developing cervical cancer, said Michelle Mitchell, director of Cancer Research UK.
“It’s amazing to see the impact of HPV vaccination. Now we can prove that it prevented hundreds of women from developing cancer in England, ‘added Prof. Peter Sasieni, lead author of the study at King’s College London. “We’ve known for many years that HPV vaccination is very effective in preventing certain strains of the virus, but it was really rewarding to see the real impact of the vaccine.
- Cervix – what diseases affect it?
Dr Vanessa Saliba, an epidemiologist at the UK Health Security Agency, added: “We encourage everyone who qualifies for the HPV vaccine to adopt it. All eligible persons can catch up by their 25th birthday.
Currently, around 3,2 people are diagnosed in the UK each year. cases of cervical cancer.
Vaccine for HPV. In Australia and Sweden, similar results
The Lancet reported in 2018 about similar effects of vaccination against the human papillomavirus (HPV) in Australia. Australia may become the first country to eliminate cervical cancer.
There, a cervical cancer screening program was introduced in 1991, and a free immunization program for girls began in 2007, which also extended to boys five years later. As a result, the number of cases of cervical cancer has dropped to seven per 100. women. This is one of the lowest rates in the world.
- How is cervical cancer diagnosed?
It has been estimated that by 2028 the number of cervical cancer cases in Australia will drop to less than four per 100 due to preventive measures (screening and vaccination).
A year ago, however, a study on the vaccination program in Sweden was published. Almost 1,7 million women were examined, of whom 528 were vaccinated. in the years 2006-2017. Compared to the unvaccinated group, the incidence of cervical cancer fell by almost 90%.
Cervical cancer – what do we know with it?
Cervical cancer is the fourth most common cancer in women in the world. Annually, about 570 thousand. women, of which about 60 percent. dies. The peak incidence is at the age of 50-60.
Nearly nine out of ten deaths occur in low- and middle-income countries where access to cervical cancer screening is low.
- Experts: Polish women do not have to die of cervical cancer
Cervical cancer is most often the result of long-term infection with the human papillomavirus HPV, especially its highly carcinogenic types (HPV16, HPV18) and belongs to malignant neoplasms.
The invasive stage of cervical cancer is preceded by cervical intraepithelial neoplasia (CIN), previously called dysplasia or pre-invasive cancer. Cervical neoplasia has no characteristic symptoms and does not pose a threat to a woman’s health. Undetected and untreated neoplasia, however, may progress to invasive cancer, which is a threat to the health and even life of a woman. This precancerous state can last from three to ten years.
Vaccinations against HPV in Poland
Compared to Australia or Great Britain, Poland is at the other extreme when it comes to HPV prophylaxis. As specialists emphasize, Poland is one of the last places in the European Union in terms of introducing the HPV vaccination program.
Our country is one of the few European countries where HPV vaccines are not fully reimbursed, and the availability of fully paid preparations is very low.
– We are the only country in Europe that does not have a universal HPV vaccination program. Vaccination initiatives have so far only been implemented locally by local governments. Unfortunately, we don’t have exact reports showing how many girls have been vaccinated so far, but I don’t think there are more than 10%. It is still a drop in the ocean. In our reality, primary prevention is just germinating, and it should be a very important element of supporting public health – said Prof. dr hab. n. med. Mariusz Bidziński, head of the Gynecological Oncology Clinic of the National Institute of Oncology in Warsaw and national consultant in the field of oncological gynecology during the June conference “Priorities and challenges in Polish and European drug policy”.
- A forgotten disease returns. “Polio can wreak havoc again”
The government finally thought about the HPV vaccination program last year. Vaccinations have been entered into the National Oncological Strategy for 2020–2030 (NSO). The document announced the launch of free vaccination against the human papillomavirus in adolescent girls, and the inclusion of boys in the program from 2026. The NSO set a target that by 2028, at least 60 percent of the number of people vaccinated is to be vaccinated. girls and boys. However, the patient was to pay for the vaccines in part.
However, vaccination plans were thwarted by the coronavirus pandemic, but they were not forgotten, they were included in the assumptions of the recently announced Polish Deal. «HPV is the most common cause of cervical cancer. In Poland, this cancer is diagnosed in about 3,5 thousand people per year. women, of which, unfortunately, about half die. In such a situation, the state cannot be idle, so we will guarantee a free vaccine against HPV ”.
HPV infection can occur either sexually or through contact with the skin of an infected person. Do you have doubts whether this applies to you? You can find HPV in-mail diagnostic testing at Medonet Market.
– I take the declarations of the Polish Order very seriously, but from a historical point of view, these initial declarations are not always implemented in a consistent manner. I also regret that the pandemic thwarted some plans and the implementation of the National Oncological Strategy (NSO) will be somewhat delayed – assessed these plans by prof. Bidziński.
Experts and representatives of the Polish medical community emphasize, however, that if HPV vaccinations are to be effective, they should be universal, fully reimbursed, at least recommended (if not mandatory) and available to patients in primary care. The government claims that at the moment there are no funds in the state budget for such a large expenditure, although it does not exclude that in the coming years the rules of financing vaccines will change.
Read also:
- Alicja Wirwicka: don’t make us die!
- The woman died of septic shock. What is sepsis?
- “Coronavirus takes entire families”. A deceased mother and daughter, the father is fighting for his life
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.